Rajasthan Cancels Licences of Pharma Distributor and Manufacturer Over Spurious Oxytocin Case
The Rajasthan drug control department cancelled the wholesale licence of Kota-based distributor M/s Rajasthan Medical Hall for supplying spurious oxytocin injections linked to five maternal deaths after Caesarean sections in May. Laboratory tests found the injections contained no oxytocin. The distributor showed discrepancies in procurement and sales records. Separately, the Centre revoked manufacturing licences of Jackson Laboratories, the Amritsar-based producer, following inspections amid ongoing investigations. The World Health Organization has requested a report from India as authorities continue probing the case.
First-hand measurement across 5 sources
We measured how 5 outlets covered this story. Coverage leans balanced overall (Left 17%, Centre 79%, Right 4%). Overall sentiment is negative (32/100). Lens Score 59/100 — moderate public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- indiatoday— balanced framing, neutral sentiment
- indianexpress— balanced framing, negative sentiment
- httpswwwoutlookindiacom— balanced framing, negative sentiment
- news18— balanced framing, negative sentiment
- hindustantimes— balanced framing, negative sentiment
AI Analysis
The article group presents perspectives primarily from government regulatory authorities and health officials, focusing on official actions and investigations. It includes statements from drug control departments and the Union Health Ministry, as well as references to the World Health Organization's involvement. There is no evident partisan framing; the coverage centers on regulatory responses and procedural developments without political commentary or opposition viewpoints.
The overall tone across the articles is serious and factual, reflecting concern over maternal deaths and drug safety issues. Coverage emphasizes regulatory measures and ongoing investigations without sensationalism. While the situation is negative due to the deaths and presence of spurious drugs, the reporting maintains a neutral, informative stance focused on accountability and public health safeguards.